trending Market Intelligence /marketintelligence/en/news-insights/trending/ODa7p8CGuwdiHxwpUCdB4A2 content esgSubNav
In This List

Ipsen to acquire equity stake in Italian consumer health company

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Ipsen to acquire equity stake in Italian consumer health company

French pharmaceutical company Ipsen agreed to acquire an equity stake in Italy-based Akkadeas Pharma, with an option to take control of the company in the future.

Akkadeas, a privately held consumer healthcare company, has a gastrointestinal-focused portfolio including probiotics, medical devices and food supplements.

As part of the deal, Akkadeas will become Ipsen's Italian distributor for Smecta, used to treat acute diarrhea in children and adults.

Financial terms of the strategic transaction were not disclosed.